Finance
Bank of Montreal (BMO) has received regulatory approval to proceed with a new normal course issuer bid, giving the Canadian bank another mechanism for managing its capital position. The authorization allows BMO to repurchase up to 25 million common shares for cancellation beginning September 8, subject to market conditions and the bank’s assessment of capital adequacy.
The new issuer bid has been approved by both the Toronto Stock Exchange and the Office of the Superintendent of Financial Institutions Canada (OSFI). It will remain available until September 7, 2027, unless completed or terminated earlier.
The maximum authorization represents approximately 3.6% of BMO’s public float and the same proportion of its issued and outstanding common shares based on figures as of August 31, 2026. BMO had 695.1 million common shares outstanding at that date, with a public float of approximately 694.8 million shares.
For the bank, the significance extends beyond the headline repurchase figure. Regulatory approval provides BMO with greater flexibility to determine how excess capital is deployed while maintaining appropriate balance-sheet requirements.
BMO will establish an automatic securities purchase plan through BMO Nesbitt Burns on September 8. Under defined criteria, the broker will be able to purchase shares on behalf of the bank.
However, the authorization does not require BMO to repurchase the full 25 million shares. The actual number of shares acquired, purchase timing and prices will depend on management’s assessment of market conditions and capital adequacy. Purchases will be conducted at prevailing market prices.
This structure gives BMO an additional capital-management tool without committing the bank to a predetermined pace of repurchases.
The new program follows BMO’s existing normal course issuer bid, which authorized the purchase of 30 million common shares beginning in September 2025. As of August 31, the bank had repurchased 23.67 million shares under that program at a volume-weighted average price of approximately $197.76 per share.
The transition to a new authorization therefore represents continuity in BMO’s capital-management framework rather than a completely new direction. The bank is maintaining the ability to reduce its outstanding share count while allowing management to adjust the pace according to financial and regulatory conditions.
For sophisticated investors, BMO’s latest announcement is principally a signal about capital flexibility. The bank has secured the regulatory capacity to repurchase shares, but its actual deployment will remain dependent on management’s judgment and the bank’s capital position.
That distinction matters. The authorization itself does not guarantee that all 25 million shares will be repurchased. Instead, it gives BMO optionality—an important characteristic for a large regulated bank managing the competing priorities of capital strength, shareholder distributions and future growth.
For a confidential discussion regarding your cross-border banking structure, capital allocation considerations and international wealth strategy, contact our senior advisory team.
Previous Post SKN | Bank of America Signals Rising Market Risk as Investor Positioning Reaches Extremes
Next Post SKN | Morgan Stanley Sees AI Capital Spending Holding Firm Despite Growing Data Center Opposition
October 17, 2026
October 16, 2026
October 16, 2026
October 16, 2026
SKN | U.S. Bancorp Earnings Highlight Stronger Profitability and Improving Operating Efficiency
SKN | Visa’s $425 Price Target Highlights Growth in Digital Payments and Stablecoin Infrastructure
SKN | UK Bank Tax Proposals Raise Concerns Over Profitability, Competitiveness and Financial Stability